MedWatch

Biogen partner calls for global Azheimer's effort

Global action must be taken in the battle against Alzheimer's according to Biogen's Japanese collaborative partner Eisai, following the US pharmaceutical company's recent drug approval in the US.

Photo: Brian Snyder/Reuters/Ritzau Scanpix

Biogen's Japanese collaborative partner Eisai is calling for global action in the battle against Alzheimer's, which the partner refers to as a "secret pandemic," according to the Financial Times.

US firm Biogen recently received approval for a drug for treating Alzheimer's in the US.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs